Sponsored Links

South Africa's Aspen Pharmacare values GSK deal at 700 million pounds

JOHANNESBURG | Wed Jul 24, 2013 7:15am EDT

JOHANNESBURG (Reuters) - South Africa's Aspen Pharmacare Holdings (APNJ.J) on Wednesday valued its bid for two of GlaxoSmithKline's (GSK.L) thrombosis drugs and a French factory at around 700 million pounds sterling, 100 million pounds of which will be for inventory.

The proposed deal was announced last month, although neither company gave a value.

(Reporting by Helen Nyambura-Mwaura; editing by David Dolan)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.